| West Coast Hospice Management, Inc. 13746 Victory Blvd., Ste. 301, Van Nuys, CA, 91401 | |
| (818) 781-1888 |
News Archive
Researchers at National Jewish Health have discovered how to prime a second arm of the immune system to potentially boost influenza vaccine effectiveness. A combination of two adjuvants, chemicals used to boost the effectiveness of some vaccines, induced CD8, or killer, T cells to join antibodies in response to influenza infection.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that a multi-center in vitro study of its proprietary triple combination antiviral drug (TCAD) therapy showed substantially greater potency against seasonal and novel H1N1 influenza viruses than currently recommended single or double therapy and that the triple combination is active against drug-resistant flu strains.
University of Pennsylvania researchers find that the variations are significant. Other news about the online health marketplaces that open next month include Oregon's decision to ditch the old system for Medicaid enrollment, a review of navigators' roles in Georgia, and Maryland officials' assurances that their system will be ready.
In some children with acute myeloid leukemia, cancer cells have the same amount of DNA changes as healthy blood stem cells.
› Verified 5 days ago
| Name | West Coast Hospice Management, Inc. |
|---|---|
| Location | 13746 Victory Blvd., Ste. 301, Van Nuys, California |
| Hospice ID | 551674 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| Accreditation Provider | The Joint Commission (TJC) |
| SSA county code | 200 |
News Archive
Researchers at National Jewish Health have discovered how to prime a second arm of the immune system to potentially boost influenza vaccine effectiveness. A combination of two adjuvants, chemicals used to boost the effectiveness of some vaccines, induced CD8, or killer, T cells to join antibodies in response to influenza infection.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that a multi-center in vitro study of its proprietary triple combination antiviral drug (TCAD) therapy showed substantially greater potency against seasonal and novel H1N1 influenza viruses than currently recommended single or double therapy and that the triple combination is active against drug-resistant flu strains.
University of Pennsylvania researchers find that the variations are significant. Other news about the online health marketplaces that open next month include Oregon's decision to ditch the old system for Medicaid enrollment, a review of navigators' roles in Georgia, and Maryland officials' assurances that their system will be ready.
In some children with acute myeloid leukemia, cancer cells have the same amount of DNA changes as healthy blood stem cells.
› Verified 5 days ago
| NPI Number | 1699084970 |
| Organization Name | West Coast Hospice Management Inc. |
| Address | 13746 Victory Blvd Van Nuys, California, 91401 |
| Phone Number | (818)781-1888 |
News Archive
Researchers at National Jewish Health have discovered how to prime a second arm of the immune system to potentially boost influenza vaccine effectiveness. A combination of two adjuvants, chemicals used to boost the effectiveness of some vaccines, induced CD8, or killer, T cells to join antibodies in response to influenza infection.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that a multi-center in vitro study of its proprietary triple combination antiviral drug (TCAD) therapy showed substantially greater potency against seasonal and novel H1N1 influenza viruses than currently recommended single or double therapy and that the triple combination is active against drug-resistant flu strains.
University of Pennsylvania researchers find that the variations are significant. Other news about the online health marketplaces that open next month include Oregon's decision to ditch the old system for Medicaid enrollment, a review of navigators' roles in Georgia, and Maryland officials' assurances that their system will be ready.
In some children with acute myeloid leukemia, cancer cells have the same amount of DNA changes as healthy blood stem cells.
› Verified 5 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 100.0 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
| Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
Researchers at National Jewish Health have discovered how to prime a second arm of the immune system to potentially boost influenza vaccine effectiveness. A combination of two adjuvants, chemicals used to boost the effectiveness of some vaccines, induced CD8, or killer, T cells to join antibodies in response to influenza infection.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that a multi-center in vitro study of its proprietary triple combination antiviral drug (TCAD) therapy showed substantially greater potency against seasonal and novel H1N1 influenza viruses than currently recommended single or double therapy and that the triple combination is active against drug-resistant flu strains.
University of Pennsylvania researchers find that the variations are significant. Other news about the online health marketplaces that open next month include Oregon's decision to ditch the old system for Medicaid enrollment, a review of navigators' roles in Georgia, and Maryland officials' assurances that their system will be ready.
In some children with acute myeloid leukemia, cancer cells have the same amount of DNA changes as healthy blood stem cells.
› Verified 5 days ago
| Home Health Aides | 3 |
| Counselors | 1 |
| Homemakers | 1 |
| Licensed Practical or Vocational Nurses | 2 |
| Medical Social Workers | 1 |
| Physicians | 2 |
| Registered Nurses | 2 |
| Total Employees | 12 |
|---|
News Archive
Researchers at National Jewish Health have discovered how to prime a second arm of the immune system to potentially boost influenza vaccine effectiveness. A combination of two adjuvants, chemicals used to boost the effectiveness of some vaccines, induced CD8, or killer, T cells to join antibodies in response to influenza infection.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that a multi-center in vitro study of its proprietary triple combination antiviral drug (TCAD) therapy showed substantially greater potency against seasonal and novel H1N1 influenza viruses than currently recommended single or double therapy and that the triple combination is active against drug-resistant flu strains.
University of Pennsylvania researchers find that the variations are significant. Other news about the online health marketplaces that open next month include Oregon's decision to ditch the old system for Medicaid enrollment, a review of navigators' roles in Georgia, and Maryland officials' assurances that their system will be ready.
In some children with acute myeloid leukemia, cancer cells have the same amount of DNA changes as healthy blood stem cells.
› Verified 5 days ago
| Others | 3 |
| Total Volunteers | 3 |
|---|
News Archive
Researchers at National Jewish Health have discovered how to prime a second arm of the immune system to potentially boost influenza vaccine effectiveness. A combination of two adjuvants, chemicals used to boost the effectiveness of some vaccines, induced CD8, or killer, T cells to join antibodies in response to influenza infection.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that a multi-center in vitro study of its proprietary triple combination antiviral drug (TCAD) therapy showed substantially greater potency against seasonal and novel H1N1 influenza viruses than currently recommended single or double therapy and that the triple combination is active against drug-resistant flu strains.
University of Pennsylvania researchers find that the variations are significant. Other news about the online health marketplaces that open next month include Oregon's decision to ditch the old system for Medicaid enrollment, a review of navigators' roles in Georgia, and Maryland officials' assurances that their system will be ready.
In some children with acute myeloid leukemia, cancer cells have the same amount of DNA changes as healthy blood stem cells.
› Verified 5 days ago
| Haga Hospice, Inc Location: 5627 Sepulveda Blvd., Suite 230, Van Nuys, California, 91411 Phone: (818) 781-1888 |
| West Coast Hospice Management, Inc. Location: 13746 Victory Blvd., Ste. 301, Van Nuys, California, 91401 Phone: (818) 781-1888 |
| Helping Hands Hospice Services Location: 7136 Haskell Avenue, Suite 302, Van Nuys, California, 91406 Phone: (818) 781-1888 |
| Heaven Hospice, Inc Location: 14557 Friar St, Ste B1, Van Nuys, California, 91411 Phone: (818) 781-1888 |